These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11344235)

  • 1. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
    Suzuki T; Darnel AD; Akahira JI; Ariga N; Ogawa S; Kaneko C; Takeyama J; Moriya T; Sasano H
    J Clin Endocrinol Metab; 2001 May; 86(5):2250-7. PubMed ID: 11344235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
    Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
    Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
    Suzuki T; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
    Int J Cancer; 2007 Jan; 120(2):285-91. PubMed ID: 17066438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
    Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
    Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters.
    Suzuki T; Moriya T; Ariga N; Kaneko C; Kanazawa M; Sasano H
    Br J Cancer; 2000 Feb; 82(3):518-23. PubMed ID: 10682658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
    Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
    Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ androgen production in human gastric carcinoma--androgen synthesizing and metabolizing enzymes.
    Nakamura Y; Shimada N; Suzuki T; Imatani A; Sekine H; Ohara S; Shimosegawa T; Sasano H
    Anticancer Res; 2006; 26(3A):1935-9. PubMed ID: 16827127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of 5alpha-reductases in human epithelial ovarian cancer: its correlation with androgen receptor status.
    Akahira JI; Suzuki T; Ito K; Darnel AD; Moriya T; Sato S; Yaegashi N; Okamura K; Sasano H
    Jpn J Cancer Res; 2001 Sep; 92(9):926-32. PubMed ID: 11572759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer.
    Shibahara Y; Miki Y; Sakurada C; Uchida K; Hata S; McNamara K; Yoda T; Takagi K; Nakamura Y; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Hum Pathol; 2013 Oct; 44(10):2338-45. PubMed ID: 23953348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
    Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM
    Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the 5alpha-reductase-3alpha-hydroxysteroid dehydrogenase complex in the human brain.
    Steckelbroeck S; Watzka M; Reichelt R; Hans VH; Stoffel-Wagner B; Heidrich DD; Schramm J; Bidlingmaier F; Klingmüller D
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1324-31. PubMed ID: 11238528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma.
    Sasano H; Frost AR; Saitoh R; Harada N; Poutanen M; Vihko R; Bulun SE; Silverberg SG; Nagura H
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4042-6. PubMed ID: 8923858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ androgen producing enzymes in human prostate cancer.
    Nakamura Y; Suzuki T; Nakabayashi M; Endoh M; Sakamoto K; Mikami Y; Moriya T; Ito A; Takahashi S; Yamada S; Arai Y; Sasano H
    Endocr Relat Cancer; 2005 Mar; 12(1):101-7. PubMed ID: 15788642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
    Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
    Suzuki T; Nakata T; Miki Y; Kaneko C; Moriya T; Ishida T; Akinaga S; Hirakawa H; Kimura M; Sasano H
    Cancer Res; 2003 Jun; 63(11):2762-70. PubMed ID: 12782580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.
    McNamara KM; Yoda T; Miki Y; Chanplakorn N; Wongwaisayawan S; Incharoen P; Kongdan Y; Wang L; Takagi K; Mayu T; Nakamura Y; Suzuki T; Nemoto N; Miyashita M; Tamaki K; Ishida T; Ohuchi N; Sasano H
    Cancer Sci; 2013 May; 104(5):639-46. PubMed ID: 23373898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
    Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
    Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.